Casdin Capital, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2020$39,592,000
-19.8%
915,0000.0%1.17%
-46.9%
Q3 2020$49,364,000
-26.8%
915,000
-17.2%
2.21%
-44.6%
Q2 2020$67,449,000
+32.8%
1,105,0000.0%3.99%
-26.0%
Q1 2020$50,786,000
-40.3%
1,105,000
+13.9%
5.39%
-31.1%
Q4 2019$85,118,000
-99.8%
970,000
+58.4%
7.83%
+34.5%
Q3 2019$56,239,750,000
+18.7%
612,500
+64.4%
5.82%
+31.2%
Q2 2019$47,382,000,000
+84142.2%
372,500
+4.2%
4.44%
-28.2%
Q1 2019$56,245,000
+71.8%
357,500
+8.3%
6.18%
+10.3%
Q4 2018$32,736,000
-13.1%
330,000
+27.9%
5.60%
+22.3%
Q3 2018$37,668,000
+20.0%
258,000
+29.0%
4.58%
+4.3%
Q2 2018$31,390,000
+26.8%
200,000
+37.9%
4.39%
+0.8%
Q1 2018$24,759,000
-4.1%
145,0000.0%4.35%
-30.8%
Q4 2017$25,825,000
+29.7%
145,0000.0%6.29%
+11.8%
Q3 2017$19,916,000
+191.7%
145,000
+123.1%
5.62%
+122.6%
Q2 2017$6,828,000
+194.6%
65,000
+154.9%
2.53%
+84.8%
Q1 2017$2,318,000
-54.5%
25,500
-69.1%
1.37%
-67.5%
Q4 2016$5,090,000
+25.2%
82,500
+37.5%
4.20%
+27.7%
Q3 2016$4,067,000
-23.3%
60,000
-51.0%
3.29%
-37.6%
Q2 2016$5,303,000
+4.0%
122,500
+2.1%
5.28%
-9.8%
Q1 2016$5,100,000
-33.8%
120,0000.0%5.85%
-14.0%
Q4 2015$7,706,000120,0006.81%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,550,000$7,518,0001.50%
Birchview Capital, LP 84,000$407,0000.29%
PDT Partners, LLC 519,485$2,520,0000.22%
OCCUDO QUANTITATIVE STRATEGIES LP 320,922$1,556,0000.13%
Virtus ETF Advisers LLC 40,607$197,0000.09%
Baker Brothers Advisors 2,499,715$12,124,0000.07%
Green Alpha Advisors, LLC 14,660$71,0000.05%
Quinn Opportunity Partners LLC 140,824$683,0000.03%
Rafferty Asset Management, LLC 979,122$4,749,0000.03%
Inspire Investing, LLC 48,724$236,0000.03%
View complete list of BLUEBIRD BIO INC shareholders